What other stocks do shareholders of Bolt Biotherapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bolt Biotherapeutics investors own include Intelsat (I) , Associated British Foods (ABF) , Chaarat Gold (CGH) , Fossil Group (FOSL) , AMC Entertainment (AMC) , Bank of America (BAC) , First Data (FDC) , Air Canada (AC) , Apollo Global Management (APO) and China Unicom (Hong Kong) (CHU) .

CNSX:BOLT

Bolt Biotherapeutics (BOLT) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free BOLT Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 71,500 shs
Average Volume: 18,200 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Bolt Biotherapeutics alerts:

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Bolt Biotherapeutics Stock (CNSX:BOLT)

Bolt Metals Corp., an exploration company, engages in the acquisition and exploration of mineral properties in Indonesia and Canada. Its flagship project is the Cyclops nickel-cobalt project covering an area of approximately 5,000 hectares located in Papua province, Indonesia. The company was formerly known as Pacific Rim Cobalt Corp. and changed its name to Bolt Metals Corp. in February 2020. Bolt Metals Corp. is headquartered in West Vancouver, Canada.

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

BOLT Stock News Headlines

March 25, 2024 | markets.businessinsider.com

Bolt Biotherapeutics’ Promising Trajectory in Immuno-Oncology: A Strong Buy Recommendation

February 9, 2024 | benzinga.com

Vivo Opportunity Fund Holdings, L.P.'s Net Worth

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

December 27, 2023 | markets.businessinsider.com

H.C. Wainwright Reaffirms Their Hold Rating on 60 Degrees Pharmaceuticals, Inc. (SXTP)

November 20, 2023 | finance.yahoo.com

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Invest In Growth?

November 10, 2023 | finanznachrichten.de

Bolt Biotherapeutics, Inc.: Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

November 7, 2023 | finance.yahoo.com

Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference

October 24, 2023 | markets.businessinsider.com

Bolt Biotherapeutics: Buy Rating Justified by Promising Clinical Results and Strong Financial Outlook

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

October 19, 2023 | markets.businessinsider.com

Bolt Biotherapeutics: First Patient Dosed In Clinical Trial Of BDC-3042

October 18, 2023 | benzinga.com

Bolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancer's 2023 Annual Meeting

October 18, 2023 | finance.yahoo.com

Bolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancer’s 2023 Annual Meeting

October 16, 2023 | finance.yahoo.com

Bolt Biotherapeutics to Present New Clinical Data from Completed Phase 1/2 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Solid Tumors at the ESMO Congress 2023

September 28, 2023 | markets.businessinsider.com

Bolt Biotherapeutics' BDC-1001 Gets FDA Orphan Drug Designation To Treat Gastric Cancers

September 12, 2023 | finance.yahoo.com

Bolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042

August 9, 2023 | finance.yahoo.com

Bolt Biotherapeutics Second Quarter 2023 Earnings: Misses Expectations

August 8, 2023 | finance.yahoo.com

Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

August 3, 2023 | finance.yahoo.com

Bolt Biotherapeutics Initiates Phase 2 Clinical Studies of BDC-1001 in Patients With HER2-Positive Cancer

July 31, 2023 | finance.yahoo.com

Bolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023

July 19, 2023 | msn.com

After COVID, a Continued Push for Diversity in Clinical Trials

June 5, 2023 | markets.businessinsider.com

H.C. Wainwright Sticks to Their Buy Rating for Bolt Biotherapeutics (BOLT)

May 30, 2023 | finance.yahoo.com

BioLight announces a joint cooperation agreement with Alexion (AstraZeneca Rare Disease) to explore an innovative technology based on natural tears for the diagnosis of retinal diseases

May 25, 2023 | finance.yahoo.com

Bolt Biotherapeutics Highlights Comprehensive Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at 2023 ASCO Annual Meeting

May 12, 2023 | msn.com

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023

May 11, 2023 | finance.yahoo.com

Bolt Biotherapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

March 30, 2023 | msn.com

Looking Into Bolt Biotherapeutics's Return On Capital Employed

February 28, 2023 | finance.yahoo.com

Bolt Biotherapeutics to Present at Cowen 43rd Annual Healthcare Conference

See More Headlines

Receive BOLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CNSX
Sector: Basic Materials
Industry: Other Industrial Metals & Mining
Sub-Industry: N/A
Current Symbol: CNSX:BOLT
CUSIP: N/A
CIK: N/A
Web: pacificrimcobalt.com
Phone: 604-922-8272
Fax: N/A
Employees: 65
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Ranjeet Sundher (Age 58)
President, CEO & Director
Comp: $202.73k
Mr. Steven Edward Vanry C.F.A.
CFA, CIM, CFO, Secretary & Director
Mr. Alwi Nabil
Country Financial Controller

Key Competitors

View All Competitors

BOLT Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Bolt Biotherapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Bolt Biotherapeutics investors own include Intelsat (I), Associated British Foods (ABF), Chaarat Gold (CGH), Fossil Group (FOSL), AMC Entertainment (AMC), Bank of America (BAC), First Data (FDC), Air Canada (AC), Apollo Global Management (APO) and China Unicom (Hong Kong) (CHU).

This page (CNSX:BOLT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bolt Biotherapeutics (BOLT) Stock Price, News & Analysis

About Bolt Biotherapeutics Stock (CNSX:BOLT)

BOLT Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

BOLT Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info